ADVANCED MALIGNANT SOLID TUMORS
Clinical trials for ADVANCED MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Not yet recruitingThis is the first time a new drug called TPD3310 is being tested in people. The study aims to find a safe dose and see if it can help control advanced solid tumors in patients who have no other effective treatments left. It will enroll adults with specific types of cancer, like l…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
New cancer drug duo enters Mid-Stage human testing
Disease control Not yet recruitingThis study is testing two new drugs, JS212 and JS213, both alone and in combination with each other and other cancer therapies, in people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to see if these treatments can shrink tumors …
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New mRNA vaccine aims to help immune system fight advanced cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of mRNA vaccine designed to target a specific protein (FAP) found in the supportive tissue around tumors. The goal is to see if the vaccine, given with standard immunotherapy drugs, is safe and can help the immune system attack advance…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:33 UTC